Excluding these special one-time items, the company earned 73 cents per share. On average, Wall Street analysts expected earnings of 70 cents per share. Global sales edged down slightly to $6.72 billion in the quarter, falling below analyst estimates of $7.07 billion. Abbott cited a stronger dollar as a reason for the downturn. Abbott reaffirmed its full-year 2009 earnings forecast of $3.65 to $3.70 per share, excluding special items. For the fiscal second quarter, the company expects profits of 87 cents to 89 cents per share. Abbott shares fell $2.16, or 4.83%, in late-morning trading Wednesday. We had removed the shares from our "Recommended" list on Oct. 9, when the stock was trading at $55.29. The dividend yield is 2.93%, based on last night's closing price of $49.20. The stock has technical support in the $37-$38 price area. If it can firm up here, we see overhead resistance in the $55-$57 range. We would stay on the sidelines for now. Abbott Labs is not recommended at this time, holding a Dividend.com DARS Rating of 3.4 out of 5 stars.